First African Ebola Vaccine Trial Begins In Mali

News outlets report on the beginning of the first African Ebola vaccine trial.

The Hill: Ebola vaccine trial begins in Africa
“The first Ebola vaccine trial in Africa has started under the supervision of the University of Maryland, according to a report. Three health care workers in Mali received the treatment, which was developed at a division of the National Institutes of Health (NIH)…” (Viebeck, 10/9).

NBC News: Exclusive: First Ebola Vaccine Trial Starts in Africa
“The first trial of an Ebola vaccine in Africa has started, researchers said Thursday, with the vaccination of three health care workers in Mali. It’s the latest vaccine to be rushed into clinical trials after the worst-ever outbreak of Ebola in West Africa turned into a full scale epidemic…” (Fox/Bratu, 10/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.